NCT01224288View on ClinicalTrials.gov

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 5, 2011

Primary Completion Date

April 30, 2029

Study Completion Date

April 30, 2029

Conditions
Renal Cell Carcinoma
Interventions
PROCEDURE

Perfusion CT scan

DCE-CT scans 4 weeks prior to and 8 weeks after starting treatment on study 2010-0085.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER